2022
Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis
Marks VA, Hsiang WR, Nie J, Demkowicz P, Umer W, Haleem A, Galal B, Pak I, Kim D, Salazar MC, Berger ER, Boffa DJ, Leapman MS. Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis. JAMA Network Open 2022, 5: e2222214. PMID: 35838668, PMCID: PMC9287756, DOI: 10.1001/jamanetworkopen.2022.22214.Peer-Reviewed Original ResearchConceptsNew cancer diagnosesMedicaid insuranceCancer careAdult patientsSkin cancerComprehensive community cancer programsMultivariable logistic regression modelMedicaid acceptanceCancer-accredited facilitiesCancer diagnosisCommunity cancer programsBreast cancer carePopulation of patientsState Medicaid expansion statusCancer care servicesFacility-level factorsAbility of patientsAmerican Hospital Association Annual SurveyMedicaid expansion statusHigh-quality careLogistic regression modelsCancer HospitalCommon cancerFindings highlight gapsCancer programs
2021
Accessibility of Telehealth services for cancer care at cancer hospital in the United States.
Marks V, Hsiang W, Nie J, Umer W, Haleem A, Galal B, Pak I, Kim D, Kenney P, Leapman M. Accessibility of Telehealth services for cancer care at cancer hospital in the United States. Journal Of Clinical Oncology 2021, 39: 6535-6535. DOI: 10.1200/jco.2021.39.15_suppl.6535.Peer-Reviewed Original ResearchMultivariable logistic regressionTelehealth servicesCancer typesTelehealth accessTelehealth availabilityNew patientsLogistic regressionCommunity cancer programsNational cross-sectional dataMedicaid Services databaseCare patientsHospital variationCancer HospitalCancer careCancer programsHospital characteristicsCancer sitesBreast cancerMajor cancersAmerican Hospital AssociationPatientsService databaseSkin cancerCancerHospital
2019
Survival rates after retroperitoneal lymph node dissection (RPLND) for testicular seminoma.
Tabakin A, Kim S, Polotti C, Shinder B, Rivera-Nunez Z, Sterling J, Farber N, Radadia K, Kim I, Singer E, Jang T. Survival rates after retroperitoneal lymph node dissection (RPLND) for testicular seminoma. Journal Of Clinical Oncology 2019, 37: 534-534. DOI: 10.1200/jco.2019.37.7_suppl.534.Peer-Reviewed Original ResearchRetroperitoneal lymph node dissectionOverall survival rateTesticular seminomaSurvival rateOverall survivalClinical stagePC settingsUnderwent retroperitoneal lymph node dissectionComprehensive community cancer programsFive-year overall survivalNational Cancer DatabaseCommunity cancer programsFirst-line treatmentLow-volume diseaseLymph node dissectionKaplan-Meier methodSurvival dataAvailable survival dataMajority of menNonseminoma histologyPrior chemotherapyNode dissectionSeminoma patientsFinal cohortOngoing trials
2015
Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma
Kashtan M, Jayakrishnan T, Rajeev R, Charlson J, Johnston F, Clark Gamblin T, Turaga K. Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. International Journal Of Clinical Oncology 2015, 21: 602-608. PMID: 26646222, DOI: 10.1007/s10147-015-0918-0.Peer-Reviewed Original ResearchConceptsNational Cancer Data BaseRetroperitoneal rhabdomyosarcomaYounger patientsSystemic chemotherapySurvival outcomesBackgroundElderly patientsComprehensive community cancer programsPoor survival outcomesCommunity cancer programsMedian survivalRadical surgeryTumor characteristicsAge-based disparitiesTumor sizePatient demographicsTreatment modalitiesPoor prognosisPoor outcomeHazard ratioShortest median distanceAcademic centersEP groupPatientsPractice patternsCancer programs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply